FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Flumazenil Injection
Status: Discontinuation
»Therapeutic Categories: Analgesia/Addiction; Neurology; Pediatric

Expand all

Mylan (Revised 12/16/2019)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
1 mg in 10 mL (0.1 mg/mL), multi-dose vial, 10 vials (NDC 67457-444-10) 07/19/2019 Discontinuation of the manufacture of the drug.
0.5 mg in 5 mL (0.1 mg/mL), multi-dose vial, 10 vials (NDC 67457-447-53) 12/16/2019 Expected Discontinuation April 2020

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English